The Cephalosporins Segment Held Largest Share of Asia Pacific Antibiotics Market in 2019
According to The Insight Partners market research study of ‘Europe Antibiotics Marketto 2027 – Regional Analysis and Forecasts by Drug Class and Action Mechanism, ’ the Europe antibiotics market is expected to reach US$ 15,569.87 millionby 2027 from US$ 12,457.70 million in 2019. The market is estimated to grow with a CAGR of 3.1% from 2020 to 2027. The report provides trends prevailing in the Europeantibiotics market and the factors driving market along with those that act as hindrances.
Based on drug class, the antibiotics market is segmented into sulfonamides, aminoglycosides, carbapenem, macrolides, fluoroquinolones, penicillin, cephalosporin, and others. The cephalosporin segment held the largest share of the market in 2019, whereas the fluoroquinolones segment is anticipated to register the highest CAGR in the market during the forecast period.Cephalosporins have continued to serve as one of the largest class of antibiotics since their discovery in the 1950s. These antibiotics are capable of treating infections that have mild life-threatening impact.
The EuropeAntibiotics marketis expected to grow owing to the prevalence of infectious diseases, and increasing development of generic drugs. However, tedious and expensive process of antibiotic development and the impact of COVID-19 pandemicareexpected to restrain the growth of the market during the forecast years.
GlaxoSmithKline plc, Sanofi, Novartis AG, Bayer AG,and Pfizer Incare some of the leading companies operating in the Europeantibiotics market.
Europe Antibiotics Market, By Regions, 2019 (%)
Europe Antibiotics Market to Grow at a CAGR of 3.1% to reach US$ 15,569.87 million from 2020 to 2027
Download Free Sample
Europe Antibiotics Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Drug Class (Sulfonamides, Aminoglycosides, Carbapenem, Macrolides, Fluoroquinolones, Penicillin, Cephalosporin, Others); Action Mechanism (Mycolic Acid Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors); and Country
Europe Antibiotics Market to Grow at a CAGR of 3.1% to reach US$ 15,569.87 million from 2020 to 2027
Download Free SampleEurope Antibiotics Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Drug Class (Sulfonamides, Aminoglycosides, Carbapenem, Macrolides, Fluoroquinolones, Penicillin, Cephalosporin, Others); Action Mechanism (Mycolic Acid Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors); and Country
The report segments Europe Antibiotics Marketas follows:
Europe Antibiotics Market– ByDrug Class
- Cephalosporin
- Penicillin
- Fluoroquinolones
- Macrolides
- Carbapenem
- Aminoglycosides
- Sulfonamides
- Others
Europe Antibiotics Market– ByAction Mechanism
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
Europe Antibiotics Market– By Geography
- Europe
- Italy
- France
- UK
- Germany
- Spain
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com